ClinicalTrials.Veeva
Menu

Find clinical trials for Non-Hodgkin Lymphoma in Charlotte, NC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Lymphoma
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Leukemia
Lymphoid Leukemia
B-Cell Chronic Lymphocytic Leukemia
Cancer

Non-Hodgkin Lymphoma trials near Charlotte, NC, USA:

A Study to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL) (TRANSCEND FL)

This is a global Phase 2, open-label, single-arm, multicohort, multicenter study to evaluate efficacy and safety of JCAR017 in adult subjects with r/...

Active, not recruiting
Lymphoma, Non-Hodgkin
Drug: Fludarabine
Drug: JCAR017

Phase 2

Celgene
Celgene

Charlotte, North Carolina, United States and 37 other locations

patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or Non-Hodgkin's Lymphomas wh...

Active, not recruiting
Non-Hodgkin's Lymphoma
Small Lymphocytic Lymphoma
Drug: CG-806

Phase 1

Aptose Biosciences

Rock Hill, South Carolina, United States of America and 29 other locations

017 works in treating patients with non-Hodgkin's lymphoma whose disease has come back or has not responded to treatment....

Active, not recruiting
Follicular Lymphoma
Mantle-cell Lymphoma
Biological: JCAR017 (lisocabtagene maraleucel) single-dose schedule
Biological: JCAR017 (lisocabtagene maraleucel) 2-dose schedule

Phase 1

Juno Therapeutics

Charlotte, North Carolina, United States and 13 other locations

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (a white blood cell responsible for fighting infections). The purp-...

Enrolling
Non-Hodgkin Lymphoma
Drug: Prednisone
Drug: Lenalidomide

Phase 2

Genmab
Genmab

Charlotte, North Carolina, United States and 74 other locations

additional open-label imaging feasibility sub-study using a tracer in adult participants with relpased/refractory B-cell non-Hodgkin...

Active, not recruiting
Non-Hodgkins Lymphoma
Drug: Tocilizumab
Drug: Atezolizumab

Phase 1, Phase 2

Roche
Roche

Charlotte, North Carolina, United States and 19 other locations

This study will evaluate the safety, efficacy, and pharmacokinetics of mosunetuzumab or glofitamab in combination with CELMoDs (CC-220 or CC-99282) i...

Enrolling
Non-Hodgkin Lymphoma
Drug: IV Glofitamab
Drug: CC-99282

Phase 1

Roche
Roche

Charlotte, North Carolina, United States and 26 other locations

bispecific antibody, in subjects with relapsed or refractory B-cell non-Hodgkin lymphoma (B-NHL) who have received 2 or mo...

Enrolling
B-cell Non Hodgkin Lymphoma
Follicular Lymphoma
Drug: AZD0486 IV

Phase 1

AstraZeneca
AstraZeneca

Charlotte, North Carolina, United States and 28 other locations

with polatuzumab vedotin in participants with diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), and mantle cell lymphoma...

Active, not recruiting
B-cell Non-Hodgkin Lymphoma
Drug: Polatuzumab vedotin
Drug: Tocilizumab

Phase 1, Phase 2

Roche
Roche

Charlotte, North Carolina, United States and 28 other locations

Locations recently updated

participants with relapsed or refractory (R/R) diffuse-large B-cell lymphoma (DLBCL), high-grade B-cell lymphoma, transformed folli...

Enrolling
Non-Hodgkin Lymphoma
Drug: Tocilizumab
Drug: Gemcitabine

Phase 3

Roche
Roche

Charlotte, North Carolina, United States and 72 other locations

or Pola-R-CHP in participants with untreated diffuse large B-cell lymphoma (DLBCL). Evaluating the safety, preliminary activity, pharmacokin...

Active, not recruiting
B-Cell Lymphoma
Non-Hodgkin Lymphoma
Drug: Obinutuzumab (G)
Drug: Doxorubicin

Phase 1

Roche
Roche

Charlotte, North Carolina, United States and 23 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems